A61K 49/0004
Screening or testing of compounds for diagnosis of disorders, assessment of conditions
Official title: {Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions}
A61K49/0004 (Screening or testing of compounds for diagnosis of disorders, assessment of conditions) appears on 1,718 US grants and 2,974 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,718
- Published applications
- 2,974
- Assignees
- 1,357
- Inventors
- 5,712
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 5 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 5 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 12 | 0 |
| 1995 | 11 | 0 |
| 1996 | 16 | 0 |
| 1997 | 25 | 0 |
| 1998 | 40 | 0 |
| 1999 | 37 | 0 |
| 2000 | 32 | 0 |
| 2001 | 39 | 16 |
| 2002 | 34 | 98 |
| 2003 | 39 | 137 |
| 2004 | 26 | 115 |
| 2005 | 33 | 188 |
| 2006 | 55 | 132 |
| 2007 | 36 | 123 |
| 2008 | 36 | 107 |
| 2009 | 47 | 100 |
| 2010 | 63 | 124 |
| 2011 | 49 | 106 |
| 2012 | 67 | 77 |
| 2013 | 61 | 120 |
| 2014 | 86 | 167 |
| 2015 | 86 | 168 |
| 2016 | 77 | 169 |
| 2017 | 99 | 167 |
| 2018 | 83 | 135 |
| 2019 | 99 | 148 |
| 2020 | 88 | 105 |
| 2021 | 70 | 113 |
| 2022 | 54 | 99 |
| 2023 | 55 | 81 |
| 2024 | 44 | 81 |
| 2025 | 39 | 57 |
| 2026 | 29 | 41 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method and composition for treating pain15 Sep 2026US 12,734,172 B2Academia Sinica
- Antibodies against human and canine IL-13RA225 Aug 2026US 12,715,926 B2Wake Forest University Health Sciences
- Non-human animals comprising a humanized ACE2 locus11 Aug 2026US 12,702,122 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animals expressing human EPO4 Aug 2026US 12,696,884 B2Institute for Research in Biomedicine (IRB)
- Method for constructing murine model with mutations in csflr gene and application thereof14 Jul 2026US 12,677,811 B2Beijing Tiantan Hospital, Capital Medical University
- Genetically Modified Non-Human Animals and Methods of Use Thereof8 Oct 2026US 2026/0305588 A1Institute for Research in Biomedicine (IRB)
- Biosensor performance indicator for intraoral appliances8 Oct 2026US 2026/0306232 A1Align Technology, Inc.
- Methods for detecting tumor disease states using conjugates including volatile organic compounds1 Oct 2026US 2026/0294272 A1Verily Life Sciences LLC
- Compound pharmaceutical preparation containing oil component comprising polyoxyethylene structure17 Sep 2026US 2026/0273107 A1Chugai Seiyaku Kabushiki Kaisha
- Fc containing polypeptides with altered glycosylation and reduced effector function17 Sep 2026US 2026/0274926 A1Genzyme Corporation
Most cited
By later US patents
- Medical scanning and treatment system and method1,502US 5,464,013 A1995
- Method and device for detecting and quantifying glucose in body fluids905US 5,342,789 ASensor Technologies, Inc. · 1994
- Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support822US 5,288,514 AThe Regents of the University of California · 1994
- Monitor for continuous in vivo measurement of glucose concentration773US 4,436,094 AEvreka, Inc. · 1984
- Backbone modified oligonucleotide analogues637US 5,610,289 AIsis Pharmaceuticals, Inc. · 1997